Stocksigma LogoStocksigma Logo

Daulat Securities Reports Q2 Results and Approves MD Designation Change

Daulat Securities approved unaudited financial results for the quarter and half-year ended 30th Sep'26

Daulat Securities Reports Q2 Results and Approves MD Designation Change

Daulat Securities Ltd · Others (Uncategorized) · 14 Nov 2026, 6:41 pm

Daulat Securities Reports Q2 Results and Approves MD Designation Change Daulat Securities approved unaudited financial results for the quarter and half-year ended 30th Sep'26. For Q2 ended 30th Sep'26, revenue from operations stood at negative ₹171.75 lacs versus ₹246.30 lacs in the preceding quarter and negative ₹25.24 lacs YoY. Net loss was ₹181.88 lacs compared to a net profit of ₹226.97 lacs in the prior quarter and a loss of ₹17.62 lacs YoY. Basic and diluted EPS stood at negative ₹3.64. The board also approved redesignating Mr. Ajit Kochar as Managing Director, subject to shareholder ratification.

Original exchange filing (PDF)

More announcements from Daulat Securities Ltd

All Daulat Securities Ltd announcements